Research Reports

Key takeaways

Ms. Susan Knight appointed Class I Director, term expires at 2028 annual meeting, joins Audit and Risk Committee.

Mr. Stephen Denaro appointed Class II Director, term expires at 2026 annual meeting, rejoins with deep Company knowledge.

Ms. Knight receives initial $250,000 RSU grant vesting over three years, subject to stockholder approval.

Both directors receive annual cash retainers per Non-Employee Director Compensation Policy.

Mr. Denaro entitled to $125,000 annual RSU if serving through annual meeting and AUD $57,645 annual fee as Company Secretary for Australian subsidiaries.

Indemnification agreements entered with both directors effective May 11, 2026.

No related party transactions under Item 404(a) of Regulation S-K.

Full analysis

The appointments strengthen the Board's expertise, with Ms. Knight bringing extensive audit committee chair experience from Surmodics, Inc., MTS Systems Corporation CFO role, and Honeywell finance positions, enhancing oversight of financial reporting and risk. Mr. Denaro's reappointment leverages his existing familiarity with Company operations and priorities, ensuring continuity. Compensation aligns with the Non-Employee Director Policy, featuring prorated cash retainers, substantial initial equity for Ms. Knight to align interests with shareholders, and standard annual grants. Mr. Denaro's subsidiary secretary role includes a modest separate fee. Indemnification agreements provide standard protection under Delaware law, supporting director recruitment without disclosed conflicts.

AVR · Anteris Technologies Global Corp.

Summary

Key takeaways

Full analysis